Brief: Neovacs Obtains U.S. Patent For Treatment Of Interpheron Alpha Related Conditions

Neovacs SA

22/02/2018 06:06

Feb 22 (Reuters) - NEOVACS SA  ALNEV.PA : 
    * HAS BEEN GRANTED BY UNITED STATES PATENT AND TRADEMARK 
OFFICE 
(USPTO) A PATENT  
    * PATENT ENTITLED "METHOD FOR TREATING INTERPHERON ALPHA 
RELATED 
CONDITIONS" 
    * ASSURES IN THIS COUNTRY PROTECTION OF ITS TECHNOLOGY 
PLATFORM 
AT LEAST UNTIL 2032 
    * RESULTS OF PHASE IIB TRIAL IN LUPUS WITH THE IFN KINOID 
SHOULD 
BE COMMUNICATED BY JUNE THIS YEAR 
 
Source text for Eikon:  ID:nGNE2LzCr  
Further company coverage:  ALNEV.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))